Page 110 - 南京医科大学学报自然科学版
P. 110
第43卷第1期
·104 · 南 京 医 科 大 学 学 报 2023年1月
有关。此外,TNFRSF19和XEDAR都缺乏胞内死亡 [7] 蔡小敏,陈正新,仇文进,等. TRAF7在胶质母细胞瘤中
域,并都可与 TRAF6 结合。因此,在皮肤附属器发 的表达及其对肿瘤增殖和迁移的影响[J]. 南京医科大
育过程中,TNFRSF19和XEDAR可能具有冗余补偿 学学报(自然科学版),2019,39(2):176-180
功能,当 XEDAR 缺陷时,TNFRSF19 突变体的脱发 [8] YONEHARA S,ISHII A,YONEHARA M. A cell⁃killing
表型可能会加重,这种推测有待进一步研究。 monoclonal antibody(anti⁃Fas)to a cell surface antigen
co⁃downregulated with the receptor of tumor necrosis fac⁃
4 结 语 tor[J]. J Exp Med,1989,169(5):1747-1756
[9] BARNHART B C,LEGEMBRE P,PIETRAS E,et al.
综上所述,TNFRSF19 这一肿瘤坏死因子受体
CD95 ligand induces motility and invasiveness of apopto⁃
超家族中的独特成员,具有重要的生理和病理功 sis ⁃ resistant tumor cells[J]. EMBO J,2004,23(15):
能,尤其是它既可抑癌又可促癌的独特性,使其日 3175-3185
益受到肿瘤生物学研究者和医学工作者的关注。 [10] DING Z,DHRUV H,KWIATKOWSKA ⁃ PIWOWARC⁃
目前,尽管对于 TNFRSF19 蛋白质的功能已有一定 ZYK A,et al. PDZ ⁃ RhoGEF is a signaling effector for
的认知,但对其在癌症和干细胞等领域的认识还处 TROY ⁃ induced glioblastoma cell invasion and survival
于探索阶段,未来对于TNFRSF19的研究,需要更多 [J]. Neoplasia,2018,20(10):1045-1058
关注以下几个方面:①进一步确认 TNFRSF19 在不 [11] PAULINO V M,YANG Z,KLOSS J,et al. TROY(TN⁃
同肿瘤中的抑癌或促癌功能;②通过分析确定不 FRSF19)is overexpressed in advanced glial tumors and
promotes glioblastoma cell invasion via Pyk2⁃Rac1 signal⁃
同细胞谱系中蛋白的互作图谱,探讨不同的细胞
ing[J]. Mol Cancer Res,2010,8(11):1558-1567
背景如何影响 TNFRSF19 的功能;③寻找并确定
[12] DENG C,LIN Y X,QI X K,et al. TNFRSF19 inhibits
TNFRSF19的配体蛋白;④探讨TNFRSF19激活下游
TGFβ signaling through interaction with TGFβ receptor
信号通路的机制和多样性;⑤TNFRSF19 对组织干 type I to promote tumorigenesis[J]. Cancer Res,2018,78
细胞的调控功能与其促癌和抑癌功能之间的联 (13):3469-3483
系。相信随着对 TNFRSF19 蛋白研究的不断深入, [13] SHAO L,ZUO X,YANG Y,et al. The inherited variations
将进一步丰富TNFRSF家族成员在人类疾病尤其是 of a p53 ⁃ responsive enhancer in 13q12.12 confer lung
恶性肿瘤中的功能与机制,为探索疾病的发病机理 cancer risk by attenuating TNFRSF19 expression[J]. Ge⁃
和新的治疗策略提供有价值的实验和理论依据。 nome Biol,2019,20(1):103
[14] KOJIMA T,MORIKAWA Y,COPELAND N G,et al.
[参考文献]
TROY,a newly identified member of the tumor necrosis
[1] MCCARTHY E F. The toxins of William B. Coley and the factor receptor superfamily,exhibits a homology with
treatment of bone and soft⁃tissue sarcomas[J]. Iowa Or⁃ Edar and is expressed in embryonic skin and hair follicles
thop J,2006,26:154-158 [J]. J Biol Chem,2000,275(27):20742-20747
[2] CARSWELL E A,OLD L J,KASSEL R L,et al. An endo⁃ [15] EBY M T,JASMIN A,KUMAR A,et al. TAJ,a novel
toxin⁃induced serum factor that causes necrosis of tumors member of the tumor necrosis factor receptor family,acti⁃
[J]. PNAS,1975,72(9):3666-3670 vates the c⁃Jun N⁃terminal kinase pathway and mediates
[3] TARTAGLIA L A,AYRES T M,WONG G H,et al. A caspase⁃independent cell death[J]. J Biol Chem,2000,
novel domain within the 55 kd TNF receptor signals cell 275(20):15336-15342
death[J]. Cell,1993,74(5):845-853 [16] HU S M,TAMADA K,NI J,et al. Characterization of TN⁃
[4] ITOH N,NAGATA S. A novel protein domain required FRSF19,a novel member of the tumor necrosis factor re⁃
for apoptosis. Mutational analysis of human Fas antigen ceptor superfamily[J]. Genomics,1999,62(1):103-107
[J]. J Biol Chem,1993,268(15):10932-10937 [17] HISAOKA T,MORIKAWA Y,KITAMURA T,et al. Ex⁃
[5] DOSTERT C,GRUSDAT M,LETELLIER E,et al. The pression of a member of tumor necrosis factor receptor su⁃
TNF family of ligands and receptors:communication mod⁃ perfamily,TROY,in the developing mouse brain[J].
ules in the immune system and beyond[J]. Physiol Rev, Brain Res Dev Brain Res,2003,143(1):105-109
2019,99(1):115-160 [18] HISAOKA T,MORIKAWA Y,SENBA E. Characteriza⁃
[6] LOCKSLEY R M,KILLEEN N,LENARDO M J. The TNF tion of TROY/TNFRSF19/TAJ ⁃ expressing cells in the
and TNF receptor superfamilies:integrating mammalian adult mouse forebrain[J]. Brain Res,2006,1110(1):81-
biology[J]. Cell,2001,104(4):487-501 94